Learn how Bayesian approaches are transforming clinical trial design by enabling adaptive studies, data borrowing, and more efficient decision-making in drug development.
Novartis used PBPK modeling for therapeutic regulatory success. They used model simulations to replace clinical studies, predict DDIs, and support asciminib’s approval.
